Fisher Funds Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Fisher Funds Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.41M	Hold	12,898	–	–	0.18%	115
2026 Q1	$5.76M	Hold	12,898	–	–	0.17%	117
2025 Q4	$5.86M	Hold	12,898	–	–	0.15%	113
2025 Q3	$5.05M	Hold	12,898	–	–	0.13%	116
2025 Q2	$5.74M	Sell	12,898 -1,433	-10%	-$660K	0.14%	108
2025 Q1	$6.95M	Hold	14,331	–	–	0.17%	102
2024 Q4	$5.77M	Buy	+14,331	New	+$6.64M	0.14%	108

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Fisher Funds Management's VRTX Position: Q2 2026 in Review

Fisher Funds Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 12,898 shares worth $6.41M. The position accounts for 0.18% of the portfolio, ranked #115.

Fisher Funds Management first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.95M in Q1 2025. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Fisher Funds Management held 12,898 shares of Vertex Pharmaceuticals worth $6.41M as of Q2 2026.
Fisher Funds Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.18% of Fisher Funds Management's portfolio in Q2 2026, its #115 holding.
Fisher Funds Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Fisher Funds Management's Vertex Pharmaceuticals position peaked at $6.95M in Q1 2025.
252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Fisher Funds Management's 13F filing for Q2 2026, filed 14 Jul 2026.